We next examined whether the observed tumor regression was dependent on adaptive immunity by inoculating the heterogeneous IFNB1/GM-CSF cell mixture into immunocompetent C57BL/6 mice and immunodeficient NSG mice. The gene discussed is CSF2; the disease is neoplasm.